Could a 'Stomach Pacemaker' stop Kids' chronic nausea?
NCT ID NCT07474415
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a device that sends small electrical pulses to the stomach can help children with severe, long-lasting nausea and vomiting. Thirty kids who hadn't gotten better with standard treatments took part. Each child had a temporary pacing lead placed through a tube into the stomach, and the device was turned off for four days and on for four days without them knowing which phase they were in. Researchers measured symptoms and how much the kids could eat or drink to see if the stimulation made a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- gastric electrical stimulation device
- What this could lead to
- If it works, this could offer a new treatment option for children with severe nausea and vomiting that hasn't responded to standard care.
- What could go wrong
- This is a small, early-stage study with only 30 participants. The results may not apply to all children, and the temporary nature of the stimulation means long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Nov 2019
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Up to 21 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \< 21 years * History of chronic nausea and vomiting refractory to medical therapy for at least 12 months * Symptoms severe enough to impact overall condition (e.g., weight loss or need for dietary modification) * Ability of participant and/or parent/guardian to provide informed consent/assent Exclusion Criteria: * Mechanical obstruction of the gastrointestinal tract. * Diagnosis of an eating disorder * Psychiatric condition deemed by the medical team to pose a safety concern for study participation * Inability of the participant to communicate symptoms * Inability of the participant or parent/guardian to read or speak English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Functional dyspepsia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound could reveal when ICU tube feeding fails
- Could a nickel allergy explain your Child's stomach pain?
- Stomach sensor may unmask hidden effects of weight-loss drugs
- A sticker-based stomach scan may replace radioactive tests for a chronic digestive disorder
- Can a stomach muscle cut tame diabetes blood sugar?
- Can a pudding snack reveal how the brain misreads the stomach?